About the journal
Journal of drug targeting is a journal published by Taylor & Francis in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Taylor & Francis
- ISSN
- 1029-2330 · 1026-7158
- Country
- United States
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- http://informahealthcare.com/drt
Index listings
- MEDLINE · 1993-01-01
- PUBMED · 2009-09-02
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2730
Last recorded publication year
2026
h-index
119
i10-index
1899
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 29%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9312476
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Advanced Drug Delivery Systems
- Advanced Drug Delivery Systems
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
Show all subjects (50)
- Advancements in Transdermal Drug Delivery
- Advancements in Transdermal Drug Delivery
- Nanoplatforms for cancer theranostics
- Nanoplatforms for cancer theranostics
- Lipid Membrane Structure and Behavior
- Lipid Membrane Structure and Behavior
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Virus-based gene therapy research
- Virus-based gene therapy research
- Monoclonal and Polyclonal Antibodies Research
- Drug Solubulity and Delivery Systems
- Drug Solubulity and Delivery Systems
- Monoclonal and Polyclonal Antibodies Research
- Graphene and Nanomaterials Applications
- Graphene and Nanomaterials Applications
- Glycosylation and Glycoproteins Research
- Glycosylation and Glycoproteins Research
- Inhalation and Respiratory Drug Delivery
- Inhalation and Respiratory Drug Delivery
- Dendrimers and Hyperbranched Polymers
- Dendrimers and Hyperbranched Polymers
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Toxin Mechanisms and Immunotoxins
- Toxin Mechanisms and Immunotoxins
- DNA and Nucleic Acid Chemistry
- DNA and Nucleic Acid Chemistry
- Ultrasound and Hyperthermia Applications
- Extracellular vesicles in disease
- Ultrasound and Hyperthermia Applications
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cell Adhesion Molecules Research
- Extracellular vesicles in disease
- Dermatology and Skin Diseases
- Cell Adhesion Molecules Research
- Dermatology and Skin Diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ